Mereo BioPharma Announces Positive Desmosine Biomarker Data from an Interim Analysis of an Investigator Initiated Study of alvelestat in Bronchiolitis Obliterans Syndrome (BOS)

NEXT STORY
Akoya Announces Rollout of Strategic Clinical Research Program to Advance Adoption of Spatial Biology for Clinical Applications
PREV STORY
Qualigen Therapeutics, Inc. to Present at the LD Micro Invitational XI Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Generex Biotechnology Announces New Updated Agenda for Shareholder Conference Call on Wednesday August 26th, 2020 at 9:30 AM

author_avatar
NASDAQ Market News

Prothena to Present Clinical Results From its Phase 1 Single Ascending Dose Study of PRX003, an Anti-MCAM Antibody Being Investigated for Inflammatory Diseases, at EULAR 2016

DUBLIN, Ireland, May 09, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage ...

author_avatar
NASDAQ Market News

I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®, I-RELIEF™ Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market

MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing ...

author_avatar
NASDAQ Market News